ECP
MDCO

Elk Creek Partners’s Medicines Co MDCO Stock Holding History

Elk Creek Partners’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-374,399
Closed -$13.7M – 123
2019
Q2 		$13.7M Sell
374,399
-385,826
-51% -$12.6M 1.02% 28
2019
Q1 		$21.2M Sell
760,225
-2,929
-0.4% -$69K 1.53% 14
2018
Q4 		$14.6M Buy
763,154
+168,802
+28% +$3.93M 1.21% 23
2018
Q3 		$17.8M Sell
594,352
-36,634
-6% -$1.38M 0.96% 35
2018
Q2 		$23.2M Buy
630,986
+14,409
+2% +$468K 1.27% 16
2018
Q1 		$20.3M Sell
616,577
-94,284
-13% -$2.95M 1.19% 23
2017
Q4 		$19.4M Buy
710,861
+17,260
+2% +$532K 1.14% 23
2017
Q3 		$25.7M Buy
693,601
+17,010
+3% +$627K 1.62% 10
2017
Q2 		$25.7M Sell
676,591
-122,113
-15% -$5.44M 1.67% 9
2017
Q1 		$39.1M Buy
798,704
+183,131
+30% +$8.35M 2.39% 4
2016
Q4 		$20.9M Buy
615,573
+215,215
+54% +$7.63M 1.41% 12
2016
Q3 		$15.1M Buy
400,358
+5,608
+1% +$211K 1% 36
2016
Q2 		$13.3M Buy
394,750
+4,241
+1% +$150K 0.95% 43
2016
Q1 		$12.4M Sell
390,509
-22,511
-5% -$735K 0.92% 43
2015
Q4 		$15.4M Buy
413,020
+101,204
+32% +$3.82M 1.1% 26
2015
Q3 		$11.8M Sell
311,816
-66,338
-18% -$2.33M 0.96% 37
2015
Q2 		$10.8M Buy
378,154
+52,304
+16% +$1.46M 0.97% 30
2015
Q1 		$9.13M Sell
325,850
-33
-0% -$927 0.95% 30
2014
Q4 		$9.02M Buy
325,883
+159,206
+96% +$3.94M 1.16% 17
2014
Q3 		$3.72M Buy
166,677
+35,393
+27% +$899K 0.97% 42
2014
Q2 		$3.81M Buy
131,284
+7,660
+6% +$205K 1.04% 38
2014
Q1 		$3.51M Buy
123,624
+58,939
+91% +$1.95M 1.51% 8
2013
Q4 		$2.5M Buy
+64,685
New +$2.31M 1.8% 5

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Elk Creek Partners's MDCO Position: Q3 2019 in Review

Elk Creek Partners sold out of Medicines Co (MDCO) in Q3 2019, closing a stake of 374,399 shares — an estimated $13.7M sold.

Elk Creek Partners first reported a position in MDCO in Q4 2013 and held it in 23 quarters. The position peaked at $39.1M in Q1 2017. 250 funds tracked by Wall St. Rank hold MDCO as of Q3 2019.

  • Elk Creek Partners reported no remaining Medicines Co position as of Q3 2019 after selling out during the quarter.
  • Elk Creek Partners sold 374,399 Medicines Co shares in Q3 2019, an estimated $13.7M.
  • Elk Creek Partners first reported a position in Medicines Co in Q4 2013 and held it in 23 quarters.
  • Elk Creek Partners's Medicines Co position peaked at $39.1M in Q1 2017.
  • 250 funds tracked by Wall St. Rank held Medicines Co as of Q3 2019.

Based on Elk Creek Partners's 13F filing for Q3 2019, filed 13 Nov 2019.